{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:58:06Z","timestamp":1781632686507,"version":"3.54.5"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Breast cancer (BC) is the most common neoplasm in women, and its growth mainly depends on estrogen, but the mechanism of estrogen in BC is still not fully understood. Circular RNAs (circRNAs) represent a novel type of regulatory RNA characterized by high evolutionary conservation and stability. This study aimed to investigate the roles and mechanisms of circRNAs in ER-positive BC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>CircKIAA1617 was identified through high-throughput RNA sequencing in ER-positive BC. Gain- and loss-of-function assays were performed to evaluate the functions of circKIAA1617 in ER-positive BC cells. Chromatin immunoprecipitation (ChIP) and luciferase assays verified the regulatory effects of estrogen on circKIAA1617 expression. RNA pulldown experiments, proteomic analyses, and RNA immunoprecipitation were conducted to identify the downstream targets of circKIAA1617.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>CircKIAA1617 expression was upregulated in ER-positive BC cells and tissues, indicating an unfavorable prognosis. In vitro and in vivo studies proved the circKIAA1617 increased the proliferation and stemness of ER-positive BC cells by inducing autophagy. Mechanistically, circKIAA1617 was activated by estrogen and cyclized by EIF4A3. Moreover, circKIAA1617 could act as a scaffold to enhance the interaction between the PGRMC1 and USP14 proteins, further increasing the stability of the PGRMC1 protein by decreasing its K48-linked polyubiquitination at lysine 105. In addition, autophagy activated by the circKIAA1617\/USP14\/PGRMC1 axis further modulated lipid metabolic reprogramming in ER-positive BC by increasing lipophagy, which accounted for the proliferation, stemness and autophagy of ER-positive BC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our results revealed that circKIAA1617 promoted the proliferation and stemness of BC cells by regulating USP14\/PGRMC1-mediated autophagy and lipid metabolic reprogramming and could serve as a potential diagnostic biomarker for ER-positive BC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12943-026-02580-2","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T08:15:47Z","timestamp":1769847347000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CircKIAA1617 promotes stemness via USP14\/PGRMC1-mediated autophagy and lipid metabolism reprogramming in ER-positive breast cancer"],"prefix":"10.1186","volume":"25","author":[{"given":"Jingwen","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zekun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinqiao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianwen","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,31]]},"reference":[{"issue":"3","key":"2580_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"17","key":"2580_CR2","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1007\/s40265-019-01208-8","volume":"79","author":"V Aggelis","year":"2019","unstructured":"Aggelis V, Johnston SRD. Advances in Endocrine-Based therapies for Estrogen Receptor-Positive metastatic breast cancer. Drugs. 2019;79(17):1849\u201366.","journal-title":"Drugs"},{"issue":"39","key":"2580_CR3","doi-asserted-by":"publisher","first-page":"eadp2442","DOI":"10.1126\/sciadv.adp2442","volume":"10","author":"S Artham","year":"2024","unstructured":"Artham S, et al. Estrogen signaling suppresses tumor-associated tissue eosinophilia to promote breast tumor growth. Sci Adv. 2024;10(39):eadp2442.","journal-title":"Sci Adv"},{"issue":"1","key":"2580_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.tem.2018.10.006","volume":"30","author":"E Kulkoyluoglu-Cotul","year":"2019","unstructured":"Kulkoyluoglu-Cotul E, Arca A, Madak-Erdogan Z. Crosstalk between Estrogen signaling and breast cancer metabolism. Trends Endocrinol Metab. 2019;30(1):25\u201338.","journal-title":"Trends Endocrinol Metab"},{"issue":"10","key":"2580_CR5","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41568-023-00604-3","volume":"23","author":"M Will","year":"2023","unstructured":"Will M, et al. Therapeutic resistance to anti-oestrogen therapy in breast cancer. Nat Rev Cancer. 2023;23(10):673\u201385.","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"2580_CR6","doi-asserted-by":"publisher","first-page":"3852","DOI":"10.1073\/pnas.73.11.3852","volume":"73","author":"HL Sanger","year":"1976","unstructured":"Sanger HL, et al. Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures. Proc Natl Acad Sci U S A. 1976;73(11):3852\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2580_CR7","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.molcel.2018.06.034","volume":"71","author":"X Li","year":"2018","unstructured":"Li X, Yang L, Chen LL. The Biogenesis, Functions, and challenges of circular RNAs. Mol Cell. 2018;71(3):428\u201342.","journal-title":"Mol Cell"},{"issue":"4","key":"2580_CR8","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.cell.2018.12.021","volume":"176","author":"JN Vo","year":"2019","unstructured":"Vo JN, et al. The landscape of circular RNA in cancer. Cell. 2019;176(4):869\u201381. e13.","journal-title":"Cell"},{"issue":"9","key":"2580_CR9","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41568-024-00721-7","volume":"24","author":"VM Conn","year":"2024","unstructured":"Conn VM, Chinnaiyan AM, Conn SJ. Circular RNA in cancer. Nat Rev Cancer. 2024;24(9):597\u2013613.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"2580_CR10","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.7150\/thno.45302","volume":"11","author":"L Wang","year":"2021","unstructured":"Wang L, et al. Estrogen-induced circRNA, circPGR, functions as a CeRNA to promote Estrogen receptor-positive breast cancer cell growth by regulating cell cycle-related genes. Theranostics. 2021;11(4):1732\u201352.","journal-title":"Theranostics"},{"issue":"2","key":"2580_CR11","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/cdd.2016.133","volume":"24","author":"WW Du","year":"2017","unstructured":"Du WW, et al. Induction of tumor apoptosis through a circular RNA enhancing Foxo3 activity. Cell Death Differ. 2017;24(2):357\u201370.","journal-title":"Cell Death Differ"},{"issue":"11","key":"2580_CR12","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1261\/rna.043687.113","volume":"20","author":"P Glazar","year":"2014","unstructured":"Glazar P, Papavasileiou, Rajewsky N. CircBase: a database for circular RNAs. RNA. 2014;20(11):1666\u201370.","journal-title":"RNA"},{"issue":"5","key":"2580_CR13","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1158\/0008-5472.CAN-21-2988","volume":"82","author":"X Jiang","year":"2022","unstructured":"Jiang X, et al. EIF4A3-Induced circARHGAP29 promotes aerobic Glycolysis in Docetaxel-Resistant prostate cancer through IGF2BP2\/c-Myc\/LDHA signaling. Cancer Res. 2022;82(5):831\u201345.","journal-title":"Cancer Res"},{"issue":"1","key":"2580_CR14","first-page":"9","volume":"9","author":"Y He","year":"2022","unstructured":"He Y, et al. Ultrasound-triggered microbubble destruction enhances the radiosensitivity of glioblastoma by inhibiting PGRMC1-mediated autophagy in vitro and in vivo. Mil Med Res. 2022;9(1):9.","journal-title":"Mil Med Res"},{"issue":"18","key":"2580_CR15","doi-asserted-by":"publisher","first-page":"14580","DOI":"10.18632\/oncotarget.24522","volume":"9","author":"L Coscujuela Tarrero","year":"2018","unstructured":"Coscujuela Tarrero L, et al. Luminal breast cancer-specific circular RNAs uncovered by a novel tool for data analysis. Oncotarget. 2018;9(18):14580\u201396.","journal-title":"Oncotarget"},{"issue":"8","key":"2580_CR16","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41419-024-06942-w","volume":"15","author":"J Zhang","year":"2024","unstructured":"Zhang J, et al. The feedback loop between MTA1 and MTA3\/TRIM21 modulates stemness of breast cancer in response to Estrogen. Cell Death Dis. 2024;15(8):597.","journal-title":"Cell Death Dis"},{"issue":"6","key":"2580_CR17","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1080\/15548627.2019.1659609","volume":"16","author":"F Yang","year":"2020","unstructured":"Yang F, et al. Stabilization of MORC2 by Estrogen and antiestrogens through GPER1- PRKACA-CMA pathway contributes to Estrogen-induced proliferation and endocrine resistance of breast cancer cells. Autophagy. 2020;16(6):1061\u201376.","journal-title":"Autophagy"},{"key":"2580_CR18","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/1476-4598-13-137","volume":"13","author":"Y Sun","year":"2014","unstructured":"Sun Y, et al. Estrogen promotes stemness and invasiveness of ER-positive breast cancer cells through Gli1 activation. Mol Cancer. 2014;13:137.","journal-title":"Mol Cancer"},{"issue":"45","key":"2580_CR19","doi-asserted-by":"publisher","first-page":"e2007949","DOI":"10.1002\/adma.202007949","volume":"33","author":"SA Yi","year":"2021","unstructured":"Yi SA, et al. Bioengineering approaches for the advanced organoid research. Adv Mater. 2021;33(45):e2007949.","journal-title":"Adv Mater"},{"issue":"8","key":"2580_CR20","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1080\/15548627.2015.1066957","volume":"11","author":"C Mauvezin","year":"2015","unstructured":"Mauvezin C, Neufeld TP. Bafilomycin A1 disrupts autophagic flux by inhibiting both V-ATPase-dependent acidification and Ca-P60A\/SERCA-dependent autophagosome-lysosome fusion. Autophagy. 2015;11(8):1437\u20138.","journal-title":"Autophagy"},{"issue":"4","key":"2580_CR21","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S0092-8674(02)00641-4","volume":"108","author":"NJ McKenna","year":"2002","unstructured":"McKenna NJ, O\u2019Malley BW. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell. 2002;108(4):465\u201374.","journal-title":"Cell"},{"issue":"20","key":"2580_CR22","doi-asserted-by":"publisher","first-page":"5215","DOI":"10.1016\/j.cell.2021.08.036","volume":"184","author":"Y Xu","year":"2021","unstructured":"Xu Y, et al. ERalpha is an RNA-binding protein sustaining tumor cell survival and drug resistance. Cell. 2021;184(20):5215\u201329. e17.","journal-title":"Cell"},{"issue":"1","key":"2580_CR23","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1080\/15476286.2015.1128065","volume":"13","author":"DB Dudekula","year":"2016","unstructured":"Dudekula DB, et al. CircInteractome: A web tool for exploring circular RNAs and their interacting proteins and MicroRNAs. RNA Biol. 2016;13(1):34\u201342.","journal-title":"RNA Biol"},{"issue":"10","key":"2580_CR24","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.4161\/auto.25889","volume":"9","author":"SU Mir","year":"2013","unstructured":"Mir SU, et al. Progesterone receptor membrane component 1\/Sigma-2 receptor associates with MAP1LC3B and promotes autophagy. Autophagy. 2013;9(10):1566\u201378.","journal-title":"Autophagy"},{"issue":"1","key":"2580_CR25","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1080\/15548627.2021.1997062","volume":"18","author":"J Knupp","year":"2022","unstructured":"Knupp J, et al. The ER transmembrane protein PGRMC1 recruits misfolded proteins for reticulophagic clearance. Autophagy. 2022;18(1):228\u201330.","journal-title":"Autophagy"},{"issue":"3","key":"2580_CR26","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3892\/ijo.2017.3873","volume":"50","author":"X Zhu","year":"2017","unstructured":"Zhu X, et al. PGRMC1-dependent autophagy by Hyperoside induces apoptosis and sensitizes ovarian cancer cells to cisplatin treatment. Int J Oncol. 2017;50(3):835\u201346.","journal-title":"Int J Oncol"},{"issue":"1","key":"2580_CR27","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12943-020-01286-3","volume":"19","author":"WY Zhou","year":"2020","unstructured":"Zhou WY, et al. Circular RNA: metabolism, functions and interactions with proteins. Mol Cancer. 2020;19(1):172.","journal-title":"Mol Cancer"},{"issue":"1","key":"2580_CR28","doi-asserted-by":"publisher","first-page":"5644","DOI":"10.1038\/s41467-022-33285-x","volume":"13","author":"D Shi","year":"2022","unstructured":"Shi D, et al. USP14 promotes Tryptophan metabolism and immune suppression by stabilizing IDO1 in colorectal cancer. Nat Commun. 2022;13(1):5644.","journal-title":"Nat Commun"},{"issue":"1","key":"2580_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41418-022-01040-w","volume":"30","author":"C Zhao","year":"2023","unstructured":"Zhao C, et al. A self-amplifying USP14-TAZ loop drives the progression and liver metastasis of pancreatic ductal adenocarcinoma. Cell Death Differ. 2023;30(1):1\u201315.","journal-title":"Cell Death Differ"},{"key":"2580_CR30","doi-asserted-by":"crossref","unstructured":"Wang C, et al. GPS-Uber: a hybrid-learning framework for prediction of general and E3-specific lysine ubiquitination sites. Brief Bioinform. 2022;23(2):1\u201315.","DOI":"10.1093\/bib\/bbab574"},{"issue":"3","key":"2580_CR31","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1152\/physrev.00024.2016","volume":"97","author":"JF Arnal","year":"2017","unstructured":"Arnal JF, et al. Membrane and nuclear Estrogen receptor alpha actions: from tissue specificity to medical implications. Physiol Rev. 2017;97(3):1045\u201387.","journal-title":"Physiol Rev"},{"issue":"3","key":"2580_CR32","doi-asserted-by":"publisher","first-page":"329","DOI":"10.11613\/BM.2014.035","volume":"24","author":"P Vrtacnik","year":"2014","unstructured":"Vrtacnik P, et al. The many faces of Estrogen signaling. Biochem Med (Zagreb). 2014;24(3):329\u201342.","journal-title":"Biochem Med (Zagreb)"},{"issue":"12","key":"2580_CR33","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1038\/s41388-018-0562-z","volume":"38","author":"S Kumar","year":"2019","unstructured":"Kumar S, et al. Estrogen-dependent DLL1-mediated Notch signaling promotes luminal breast cancer. Oncogene. 2019;38(12):2092\u2013107.","journal-title":"Oncogene"},{"issue":"1","key":"2580_CR34","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00018-025-05639-3","volume":"82","author":"R Chi","year":"2025","unstructured":"Chi R, et al. Estrogen-induced circFAM171A1 regulates sheep myoblast proliferation through the oar-miR-485-5p\/MAPK15\/MAPK pathway. Cell Mol Life Sci. 2025;82(1):123.","journal-title":"Cell Mol Life Sci"},{"key":"2580_CR35","doi-asserted-by":"publisher","first-page":"102344","DOI":"10.1016\/j.redox.2022.102344","volume":"53","author":"W Liu","year":"2022","unstructured":"Liu W, et al. TRIM22 inhibits osteosarcoma progression through destabilizing NRF2 and thus activation of ROS\/AMPK\/mTOR\/autophagy signaling. Redox Biol. 2022;53:102344.","journal-title":"Redox Biol"},{"issue":"12","key":"2580_CR36","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1080\/15548627.2022.2051880","volume":"18","author":"CH Kao","year":"2022","unstructured":"Kao CH, et al. TFEB- and TFE3-dependent autophagy activation supports cancer proliferation in the absence of centrosomes. Autophagy. 2022;18(12):2830\u201350.","journal-title":"Autophagy"},{"issue":"5","key":"2580_CR37","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1093\/neuonc\/noad264","volume":"26","author":"D Liu","year":"2024","unstructured":"Liu D, et al. Hypoxia-induced galectin-8 maintains stemness in glioma stem cells via autophagy regulation. Neuro Oncol. 2024;26(5):872\u201388.","journal-title":"Neuro Oncol"},{"issue":"9","key":"2580_CR38","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.tem.2015.06.007","volume":"26","author":"C Thomas","year":"2015","unstructured":"Thomas C, Gustafsson JA. Estrogen receptor mutations and functional consequences for breast cancer. Trends Endocrinol Metab. 2015;26(9):467\u201376.","journal-title":"Trends Endocrinol Metab"},{"issue":"20","key":"2580_CR39","doi-asserted-by":"publisher","first-page":"4399","DOI":"10.1158\/0008-5472.CAN-20-1031","volume":"80","author":"Z Fang","year":"2020","unstructured":"Fang Z, et al. Is an Estrogen-Responsive LncRNA that drives breast cancer through the E2F1\/RB1 pathway. Cancer Res. 2020;80(20):4399\u2013413.","journal-title":"Cancer Res"},{"issue":"1","key":"2580_CR40","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1210\/me.2010-0294","volume":"25","author":"Y Wang","year":"2011","unstructured":"Wang Y, et al. SGK3 is an estrogen-inducible kinase promoting estrogen-mediated survival of breast cancer cells. Mol Endocrinol. 2011;25(1):72\u201382.","journal-title":"Mol Endocrinol"},{"issue":"24","key":"2580_CR41","doi-asserted-by":"publisher","first-page":"4568","DOI":"10.7150\/jca.27655","volume":"9","author":"Y Lin","year":"2018","unstructured":"Lin Y, et al. Systematic analysis of gene expression alteration and Co-Expression network of eukaryotic initiation factor 4A-3 in cancer. J Cancer. 2018;9(24):4568\u201377.","journal-title":"J Cancer"},{"issue":"1","key":"2580_CR42","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12943-024-02037-4","volume":"23","author":"Y Liang","year":"2024","unstructured":"Liang Y, et al. Exosomal circSIPA1L3-mediated intercellular communication contributes to glucose metabolic reprogramming and progression of triple negative breast cancer. Mol Cancer. 2024;23(1):125.","journal-title":"Mol Cancer"},{"issue":"1","key":"2580_CR43","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12943-020-01183-9","volume":"19","author":"X Zheng","year":"2020","unstructured":"Zheng X, et al. The circrna circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer. Mol Cancer. 2020;19(1):73.","journal-title":"Mol Cancer"},{"issue":"7418","key":"2580_CR44","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11412","volume":"490","author":"N Cancer Genome Atlas","year":"2012","unstructured":"Cancer Genome Atlas N. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61\u201370.","journal-title":"Nature"},{"issue":"1","key":"2580_CR45","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41467-020-20527-z","volume":"12","author":"B Li","year":"2021","unstructured":"Li B, et al. circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity. Nat Commun. 2021;12(1):295.","journal-title":"Nat Commun"},{"key":"2580_CR46","unstructured":"Bahrulolum H, et al. CircRNA: unlocking new frontiers in therapeutic and vaccine development. Mol Ther. 2025.S1525-0016(25)00859-7. Advance online publication."},{"key":"2580_CR47","doi-asserted-by":"publisher","first-page":"108326","DOI":"10.1016\/j.pharmthera.2022.108326","volume":"241","author":"MR McGuire","year":"2023","unstructured":"McGuire MR, Espenshade PJ. PGRMC1: an enigmatic heme-binding protein. Pharmacol Ther. 2023;241:108326.","journal-title":"Pharmacol Ther"},{"issue":"2","key":"2580_CR48","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/GME.0000000000001436","volume":"27","author":"X Ruan","year":"2020","unstructured":"Ruan X, et al. Association of Circulating progesterone receptor membrane Component-1 (PGRMC1) with breast tumor characteristics and comparison with known tumor markers. Menopause. 2020;27(2):183\u201393.","journal-title":"Menopause"},{"issue":"1","key":"2580_CR49","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.pharmthera.2008.09.006","volume":"121","author":"HJ Rohe","year":"2009","unstructured":"Rohe HJ, et al. PGRMC1 (progesterone receptor membrane component 1): a targetable protein with multiple functions in steroid signaling, P450 activation and drug binding. Pharmacol Ther. 2009;121(1):14\u20139.","journal-title":"Pharmacol Ther"},{"issue":"2","key":"2580_CR50","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/13697137.2023.2170225","volume":"26","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, et al. PGRMC1 promotes triple-negative breast cancer cell growth via suppressing ferroptosis. Climacteric. 2023;26(2):135\u201342.","journal-title":"Climacteric"},{"issue":"7","key":"2580_CR51","doi-asserted-by":"publisher","first-page":"167440","DOI":"10.1016\/j.bbadis.2024.167440","volume":"1870","author":"A Guan","year":"2024","unstructured":"Guan A, et al. PGRMC1 promotes NSCLC stemness phenotypes by disrupting TRIM56-mediated ubiquitination of AHR. Biochim Biophys Acta Mol Basis Dis. 2024;1870(7):167440.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"5","key":"2580_CR52","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.cell.2005.11.007","volume":"123","author":"SM Nijman","year":"2005","unstructured":"Nijman SM, et al. A genomic and functional inventory of deubiquitinating enzymes. Cell. 2005;123(5):773\u201386.","journal-title":"Cell"},{"issue":"1","key":"2580_CR53","doi-asserted-by":"publisher","first-page":"4770","DOI":"10.1038\/s41467-018-07185-y","volume":"9","author":"B Liu","year":"2018","unstructured":"Liu B, et al. Proteome-wide analysis of USP14 substrates revealed its role in hepatosteatosis via stabilization of FASN. Nat Commun. 2018;9(1):4770.","journal-title":"Nat Commun"},{"issue":"11","key":"2580_CR54","doi-asserted-by":"publisher","first-page":"3483","DOI":"10.7150\/ijbs.84331","volume":"19","author":"L You","year":"2023","unstructured":"You L, et al. SDC2 stabilization by USP14 promotes gastric cancer progression through Co-option of PDK1. Int J Biol Sci. 2023;19(11):3483\u201398.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"2580_CR55","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12943-020-01262-x","volume":"19","author":"T Sun","year":"2020","unstructured":"Sun T, Liu Z, Yang Q. The role of ubiquitination and deubiquitination in cancer metabolism. Mol Cancer. 2020;19(1):146.","journal-title":"Mol Cancer"},{"issue":"10","key":"2580_CR56","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/s41419-023-06154-8","volume":"14","author":"S Liu","year":"2023","unstructured":"Liu S, et al. Autophagy: regulator of cell death. Cell Death Dis. 2023;14(10):648.","journal-title":"Cell Death Dis"},{"issue":"1","key":"2580_CR57","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40880-018-0301-4","volume":"38","author":"C Cheng","year":"2018","unstructured":"Cheng C, et al. Lipid metabolism reprogramming and its potential targets in cancer. Cancer Commun (Lond). 2018;38(1):27.","journal-title":"Cancer Commun (Lond)"},{"key":"2580_CR58","doi-asserted-by":"publisher","first-page":"155905","DOI":"10.1016\/j.metabol.2024.155905","volume":"155","author":"Y Yang","year":"2024","unstructured":"Yang Y, et al. Interplay of CD36, autophagy, and lipid metabolism: insights into cancer progression. Metabolism. 2024;155:155905.","journal-title":"Metabolism"},{"issue":"3","key":"2580_CR59","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1080\/15548627.2023.2259732","volume":"20","author":"Z Lin","year":"2024","unstructured":"Lin Z, et al. The lipid basis of cell death and autophagy. Autophagy. 2024;20(3):469\u201388.","journal-title":"Autophagy"},{"issue":"10","key":"2580_CR60","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1080\/15548627.2023.2213984","volume":"19","author":"Q Li","year":"2023","unstructured":"Li Q, et al. Impaired lipophagy induced-microglial lipid droplets accumulation contributes to the buildup of TREM1 in diabetes-associated cognitive impairment. Autophagy. 2023;19(10):2639\u201356.","journal-title":"Autophagy"},{"issue":"2","key":"2580_CR61","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41419-022-04593-3","volume":"13","author":"S Zhang","year":"2022","unstructured":"Zhang S, et al. The regulation, function, and role of lipophagy, a form of selective autophagy, in metabolic disorders. Cell Death Dis. 2022;13(2):132.","journal-title":"Cell Death Dis"},{"issue":"7","key":"2580_CR62","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41569-023-00885-z","volume":"20","author":"T Laval","year":"2023","unstructured":"Laval T, Ouimet M. A role for lipophagy in atherosclerosis. Nat Rev Cardiol. 2023;20(7):431\u20132.","journal-title":"Nat Rev Cardiol"},{"issue":"11","key":"2580_CR63","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.tem.2021.08.010","volume":"32","author":"M Haidar","year":"2021","unstructured":"Haidar M, et al. Lipophagy: a new player in CNS disorders. Trends Endocrinol Metab. 2021;32(11):941\u201351.","journal-title":"Trends Endocrinol Metab"},{"issue":"3","key":"2580_CR64","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1002\/jcp.29182","volume":"235","author":"PK Panda","year":"2020","unstructured":"Panda PK, et al. Deacetylation of LAMP1 drives lipophagy-dependent generation of free fatty acids by abrus agglutinin to promote senescence in prostate cancer. J Cell Physiol. 2020;235(3):2776\u201391.","journal-title":"J Cell Physiol"},{"key":"2580_CR65","doi-asserted-by":"publisher","first-page":"216241","DOI":"10.1016\/j.canlet.2023.216241","volume":"565","author":"Y Shao","year":"2023","unstructured":"Shao Y, et al. The feedback loop of AURKA\/DDX5\/TMEM147-AS1\/let-7 drives lipophagy to induce cisplatin resistance in epithelial ovarian cancer. Cancer Lett. 2023;565:216241.","journal-title":"Cancer Lett"},{"issue":"1","key":"2580_CR66","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1186\/s13046-021-02168-2","volume":"40","author":"JH You","year":"2021","unstructured":"You JH, Lee J, Roh JL. PGRMC1-dependent lipophagy promotes ferroptosis in paclitaxel-tolerant persister cancer cells. J Exp Clin Cancer Res. 2021;40(1):350.","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"2580_CR67","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.cmet.2018.06.001","volume":"28","author":"AS Divakaruni","year":"2018","unstructured":"Divakaruni AS, et al. Etomoxir inhibits macrophage polarization by disrupting coa homeostasis. Cell Metab. 2018;28(3):490\u2013503. e7.","journal-title":"Cell Metab"},{"issue":"3","key":"2580_CR68","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/s41419-022-04677-0","volume":"13","author":"Z He","year":"2022","unstructured":"He Z, et al. Autophagy-associated circrna circATG7 facilitates autophagy and promotes pancreatic cancer progression. Cell Death Dis. 2022;13(3):233.","journal-title":"Cell Death Dis"},{"issue":"1","key":"2580_CR69","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12943-020-01152-2","volume":"19","author":"G Liang","year":"2020","unstructured":"Liang G, et al. Autophagy-associated circrna circcdyl augments autophagy and promotes breast cancer progression. Mol Cancer. 2020;19(1):65.","journal-title":"Mol Cancer"},{"issue":"9","key":"2580_CR70","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1080\/15548627.2023.2196889","volume":"19","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, et al. CircEPS15, as a sponge of MIR24-3p ameliorates neuronal damage in Parkinson disease through boosting PINK1-PRKN-mediated mitophagy. Autophagy. 2023;19(9):2520\u201337.","journal-title":"Autophagy"},{"issue":"2","key":"2580_CR71","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/15548627.2018.1520549","volume":"15","author":"J Xiang","year":"2019","unstructured":"Xiang J, et al. How does Estrogen work on autophagy? Autophagy. 2019;15(2):197\u2013211.","journal-title":"Autophagy"},{"key":"2580_CR72","doi-asserted-by":"crossref","unstructured":"Zhao Y, et al. The estrogen-autophagy axis: insights into cytoprotection and therapeutic potential in cancer and infection. Int J Mol Sci. 2024;25(23):12576.","DOI":"10.3390\/ijms252312576"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-026-02580-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02580-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02580-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:27:05Z","timestamp":1781630825000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12943-026-02580-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,31]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2580"],"URL":"https:\/\/doi.org\/10.1186\/s12943-026-02580-2","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,31]]},"assertion":[{"value":"9 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experimental procedures conducted in this study received approval from the Ethical Committee of Shandong University (Approval Number: KYLL-2022(ZM)-1058). Tissue samples were obtained from patients admitted to Qilu Hospital at the time of surgery and promptly stored at -80 \u00b0C. Written informed consent was obtained from all participating patients prior to their inclusion in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the final version of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"55"}}